198 related articles for article (PubMed ID: 31823505)
1. Serum levels of interleukin-34 and clinical correlation in patients with primary Sjögren's syndrome.
Liu Y; Zhang B; Lei Y; Xia L; Lu J; Shen H
Int J Rheum Dis; 2020 Mar; 23(3):374-380. PubMed ID: 31823505
[TBL] [Abstract][Full Text] [Related]
2. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
3. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
7. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
8. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
[TBL] [Abstract][Full Text] [Related]
9. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren's syndrome.
Liuqing W; Liping X; Hui S; Jing L
J Investig Med; 2017 Mar; 65(3):717-721. PubMed ID: 28057714
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
11. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
12. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
[TBL] [Abstract][Full Text] [Related]
13. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
[TBL] [Abstract][Full Text] [Related]
14. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
Toker E; Yavuz S; Direskeneli H
Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury.
Jin Y; Li J; Chen J; Shao M; Zhang R; Liang Y; Zhang X; Zhang X; Zhang Q; Li F; Cheng Y; Sun X; He J; Li Z
J Immunol Res; 2019; 2019():3642937. PubMed ID: 31205955
[TBL] [Abstract][Full Text] [Related]
17. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
18. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
Hernández-Molina G; Bermúdez-Bermejo P
Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
20. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]